
Navigating the Logistics Impact
Cell and gene therapies (CGTs) present a revolutionary approach to the pharmaceutical industry. However, several complexities do arise on a logistical spectrum that diverge from those of traditional pharmaceuticals.
Cell and gene therapies (CGTs) present a revolutionary approach to the pharmaceutical industry. However, several complexities do arise on a logistical spectrum that diverge from those of traditional pharmaceuticals.
An innovative manufacturing platform called integrated continuous manufacturing (ICM) represents a completely modernized model for drug manufacturing. In contrast to batch processes, ICM’s unique operational advantages will allow for cost-competitive end-to-end manufacturing and enable a more robust and responsive supply chain for critical drugs.
Headquartered in Cramlington, UK, Sterling Pharma Solutions is a contract development and manufacturing organization (CDMO) that provides a range of services to the global biopharmaceutical industry, including active pharmaceutical ingredient (API) development, scale-up and cGMP manufacturing, as well as antibody drug conjugate (ADC) R&D and clinical-scale GMP manufacturing.
mRNA-based vaccines against the coronavirus have become firmly established in medicine since the pandemic. Nevertheless, the technology is still at the beginning of its potential. Experts see a wide range of potential applications for this relatively new technology, particularly in infectious diseases and cancer.
Numerous articles have been published within the last years in chemical science and business media (including this one) on the advantages of continuous reactions, aka flow chemistry.
Artificial intelligence (AI) can help companies in the process industry capture, retain and access valuable historical expertise and ease the transition for new colleagues in the plant.
Generative AI can impact the field of chromatography in various innovative ways. However, great care needs to be taken to validate any use of this emerging technology from a technical, quality and regulatory perspective.
Aralez Bio, a San Francisco-based start-up, has engineered a platform of enzymes that creates 100 times more compound diversity using processes that are also 50 times greener than conventional methods.
Interview with Markus Mau, President of the ELA, about developments for the logistics sector.
Biorefining allows low-carbon feedstocks – such as lignocellulosic biomass – to be processed into intermediate chemicals that can be made into renewable plastics for the automotive industry. Sonichem has developed a breakthrough biorefinery technique that uses ultrasonic energy alongside mild organic acids to fractionate softwood sawdust into hemicellulose sugars, microcrystalline cellulose and high-quality lignin.
The logistics industry urgently needs digital transformation to ensure quality and to tackle challenges such as the shortage of skilled workers and sustainability.
The pharmaceutical industry is a truly global and complex network of ingredients and materials suppliers, manufacturers, distributors for a variety of products ranging from vaccines to antibiotics and to therapeutic drugs for customers/patients.